Mitochondrial Diabetes

TABLE 1

Characteristics of the study cohort examined by a hyperglycemic clamp

n BMI (kg/m2) Fasting glucose (mmol/l) HbA1c (%) First-phase insulin (pmol/l)* Second-phase insulin (pmol/l)
Noncarriers 90 28.4 6.56 5.7 694 312
A3243G carriers 2 24.7 6.35 5.9 390 141
  • *

    * First-phase integrated insulin concentrations at 2.5, 5, 7, and 10 min after application of 10 mmol/l hyperglycemia.

  • Second-phase average insulin concentration in the 120- to 180-min range, minus basal.

This Article

  1. Diabetes vol. 53 no. suppl 1 S103-S109